Rankings
▼
Calendar
AXSM
Axsome Therapeutics, Inc.
$8B
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$7M
EPS (Diluted)
$-0.36
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$482,033
Balance Sheet
Total Assets
$40M
Total Liabilities
$5M
Stockholders' Equity
$35M
Cash & Equivalents
$39M
← FY 2016
All Quarters
Q3 2016 →
AXSM Q2 2016 Earnings — Axsome Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
